Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer

por Fertal, Shelby A., Poterala, Johanna E., Ponik, Suzanne M., Wisinski, Kari B.
Publicado 2022

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)

por Leal, Ticiana A., Sharifi, Marina N., Chan, Nancy, Wesolowski, Robert, Turk, Anita A., Bruce, Justine Y., O'Regan, Ruth M., Eickhoff, Jens, Barroilhet, Lisa M., Malhotra, Jyoti, Mehnert, Janice, Girda, Eugenia, Wiley, Elizabeth, Schmitz, Natalie, Andrews, Shannon, Liu, Glenn, Wisinski, Kari B.
Publicado 2022

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

por Choudhury, Atish D., Higano, Celestia S., de Bono, Johann S., Cook, Natalie, Rathkopf, Dana E., Wisinski, Kari B., Martin-Liberal, Juan, Linch, Mark, Heath, Elisabeth I., Baird, Richard D., García-Carbacho, Javier, Quintela-Fandino, Miguel, Barry, Simon T., de Bruin, Elza C., Colebrook, Steve, Hawkins, George, Klinowska, Teresa, Maroj, Brijesh, Moorthy, Ganesh, Mortimer, Peter G., Moschetta, Michele, Nikolaou, Myria, Sainsbury, Liz, Shapiro, Geoffrey I., Siu, Lillian L., Hansen, Aaron R.
Publicado 2022